Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Hyper-IL-6 syndrome mimicking IgG4-related disease].
Terao T, Yamamoto K, Ikeuchi K, Wakabayashi H, Igawa T, Inoue D, Oda W, Oyama T, Kamoi C, Sumii Y, Shiraishi Y, Yamamoto Y, Niiya D, Shiote Y, Sato Y, Yoshino T, Imajo K. Terao T, et al. Among authors: kamoi c. Rinsho Ketsueki. 2019;60(5):392-397. doi: 10.11406/rinketsu.60.392. Rinsho Ketsueki. 2019. PMID: 31168001 Japanese.
[Successful treatment with enzyme replacement therapy for pelvic fragile fracture in an elderly case of type I Gaucher's disease].
Matsubara C, Yamamoto K, Maeda T, Itakura J, Uehara T, Shiote Y, Adachi K, Kamoi C, Oyama T, Shiraishi Y, Yamamoto Y, Niiya D, Yoshida C, Nanba E, Ueda Y, Imajo K. Matsubara C, et al. Among authors: kamoi c. Rinsho Ketsueki. 2020;61(12):1654-1659. doi: 10.11406/rinketsu.61.1654. Rinsho Ketsueki. 2020. PMID: 33441516 Japanese.
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel.
Terao T, Kitamura W, Fujii N, Asada N, Kamoi C, Fujiwara K, Kondo K, Matsubara C, Hayashino K, Seike K, Fujiwara H, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y. Terao T, et al. Among authors: kamoi c. Transplant Cell Ther. 2023 Sep;29(9):573.e1-573.e8. doi: 10.1016/j.jtct.2023.06.018. Epub 2023 Jul 1. Transplant Cell Ther. 2023. PMID: 37394114
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma.
Hayashino K, Seike K, Fujiwara K, Kondo K, Matsubara C, Terao T, Kitamura W, Kamoi C, Fujiwara H, Asada N, Nishimori H, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Hayashino K, et al. Among authors: kamoi c. Int J Hematol. 2024 Apr;119(4):459-464. doi: 10.1007/s12185-024-03711-5. Epub 2024 Feb 13. Int J Hematol. 2024. PMID: 38349446 Free PMC article.